Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
株式のランク #29818
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
株価
$7.00
最終同期: 2026-08-17
時価総額
$19.47M
変化(1日)
0.00%
変化(1年)
-35.19%
CA
取引 Devonian Health Group Inc. (DVHGF)

カテゴリー

Devonian Health Group Inc.(DVHGF)の株式分割履歴
Devonian Health Group Inc.株(シンボル:DVHGF)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 19, 2026に行われました。
Aug 19, 2026より前に購入されたDVHGF株は、現在0DVHGF株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR